OR WAIT null SECS
NGS abbreviates drug discovery timelines.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
Developing cell-based potency assays for cell therapies requires meticulous coordination.
October 24, 2024
The importance of proper analysis of HCPs in the biomanufacturing process was discussed by Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, at AAPS PharmSci 360.
October 22, 2024
At AAPS PharmSci 360.Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed trends in new analytical tools for RNA characterization and gave highlights from his presentation.
October 05, 2024
The best strategy is to use a combination of complementary methods.
October 04, 2024
Contract organizations offer assistance for testing raw materials obtained from outside suppliers.
September 11, 2024
The new Vivaflow SU tangential flow filtration cassette is designed to be more flexible and user-friendly and offers enhanced ultrafiltration and diafiltration efficiency.
September 05, 2024
Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.
September 04, 2024
As the field of bioanalytical testing evolves, it is important for drug developers to stay at the forefront of the advancements to ensure they remain competitive.
August 05, 2024
Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.
July 12, 2024
With the acquisition, Olink will join Thermo Fisher’s Life Sciences Solutions business.
June 07, 2024
Raphael Townshend, founder and CEO of Atomic AI, speaks on AI’s usefulness in characterizing molecular structure and advancing molecular engineering.